Sign Up to like & get
recommendations!
0
Published in 2020 at "Cancer Immunology, Immunotherapy"
DOI: 10.1007/s00262-020-02624-6
Abstract: Target expression heterogeneity and the presence of an immunosuppressive microenvironment can hamper severely the efficiency of immunotherapeutic approaches. We have analyzed the potential to encounter and overcome such conditions by a combinatory two-target approach involving…
read more here.
Keywords:
antibody;
costimulation;
immunosuppressive factors;
expression ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Biomedicines"
DOI: 10.3390/biomedicines10123209
Abstract: The immunosuppressive tumor microenvironment (TME) consists of suppressive cells producing a variety of immunomodulatory proteins, such as programmed death ligand 1 (PD-L1) and indoleamine-2,3-dioxygenase (IDO). Although granzyme B (GrB) is known to convey the cytolytic…
read more here.
Keywords:
grb lymphocytes;
melanoma;
cd8 cytotoxic;
immunosuppressive factors ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Oncology Letters"
DOI: 10.3892/ol.2018.8026
Abstract: Hepatocellular carcinoma (HCC) is the most common form of primary liver cancer. γδ T cells have been revealed to be promising candidates for immunotherapy in patients with HCC. However, the use of these cells in…
read more here.
Keywords:
hepatocellular carcinoma;
immunotherapy;
clinicopathological characteristics;
immunosuppressive factors ... See more keywords